Skip to main content

Stocks to Watch in May 2023: FOBI.V / FOBIF, NWBO, ENZC, GEVI

Here are several stocks exhibiting breakout potential characteristics which should be added to your watch list in May 2023.

Fobi AI Inc. (TSX.V: FOBI)(OTCQB: FOBIF): On May 8, the company reported a robust 298% year-over-year jump in revenue for the third quarter ended on March 31, 2023.

Fobi AI Inc is involved in using the power of artificial intelligence and data intelligence for enabling digital transformation. The company provides artificial intelligence and data intelligence applications in real-time to businesses so as to bring in digital transformations. The company is a well-known data intelligence and tech firm in North America and Europe. It is also the biggest data aggregating firm in the tourism and hospitality industries in Canada.

Northwest Biotherapeutics (OTC:NWBO): is a unique biotech company that is focused on the development of personalized immunotherapy products meant for the treatment of cancers with more effectiveness than contemporary options. The treatments do not contain any toxicities which are associated with chemotherapy and are supposed to be more cost-effective too.

On March 21, the company made the joint announcement with Advent BioServices that an MIA license was approved and issued by the Medicines and Healthcare Products Regulatory Agency (MHRA) for the commercial manufacturing of cell therapy products at the GMP facility in Sawston, U.K.

Enzolytics Inc (OTC:ENZC): Medicine development company Enzolytics Inc is focused on the commercialization and development of monoclonal antibodies and proprietary proteins which are meant for the treatment of infectious diseases. At this point, Enzolytics is working on the advancement of multiple therapeutics, which could treat several infectious diseases.

On April 27, the company announced that a business combination had been consummated between its operating subsidiaries Virogentics and Biogenysis, with Sagaliam Acquisition Corp. Considering the change in ownership structure, Enzolytics appointed Dr. Gaurav Chandra as the Chairman and Chief Executive Officer of Biogenysis. The company noted at the time that it was making meaningful progress in completing the business combination with Sagaliam.

General Enterprise Venture Inc (OTC:GEVI) - Since mid-April, the stock has been witnessing significant gains with a jump of over 100%. Moreover, the stock is now trading at a multi-month high.

General Enterprise Venture is best known for the work being done by its fully owned subsidiary unit Mighty Fire Breaker, which developed the environmentally friendly fire-resistant MFB-31-CitroTech.

In March this year, the company announced that it had started sending out samples as well as marketing and technical information materials to retailers all over the United States. The product has also won certifications from the EPA Safer Choice Program, LENS, and UL GreenGold. It was also put through the California Aquatic Bioassay testing and had been certified non-hazardous and non-toxic.

The company said in March that the rollout of the samples of its product to retailers in the United States was expected to be a success. It noted that it had already sent some samples to many of the local stores prior to the rollout and the response had been overwhelmingly positive.

Throughout last year, the company worked with a single-minded focus to win 10 accreditations for MFB-31-CitroTech. Those accreditations made the product a unique one in its category. It had worked with a number of laboratories to get those accreditations. All the substances developed by Mighty Fire Breaker had Zero Volatile Organic Compounds and hence, safe for both outdoor and indoor use.


Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.“TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.